Established Status Epilepticus Treatment Trial

Completed · Phase 3

Conditions studied: Benzodiazepine Refractory Status Epilepticus

In brief

The primary objective is to determine the most effective and/or the least effective treatment of benzodiazepine-refractory status epilepticus (SE) among patients older than 2 years. There are three active treatment arms being compared: fosphenytoin (FOS),levetiracetam (LEV), and valproic acid (VPA). The second objective is comparison of three drugs with respect to secondary outcomes. The final objective is to ensure that the trial is informative for treatment of established SE in children by describing the effectiveness, safety, and rate of adverse reactions of these drugs in children.

Key facts

Study ID
NCT01960075
Run by
University of Virginia
People needed
478
Starts
2015-10-01
Expected to finish
2019-05-01
Last updated by the study team
2021-06-14

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.